Online Strattera (Atomoxetine)
Neurology & Migraine • Educational only; not medical advice. Prescriptions at clinician discretion.
Overview
Atomoxetine, marketed as Strattera, is a selective norepinephrine-reuptake inhibitor (NRI) used to treat attention-deficit/hyperactivity disorder (ADHD). Unlike stimulants, it lacks abuse potential and provides 24-hour symptom control.
Uses
Indicated for ADHD in children over 6 years, adolescents, and adults. It may benefit patients who cannot tolerate or have contraindications to stimulants such as methylphenidate.Dosage & Administration
Initial dose: 0.5 mg/kg/day, increased after several days to 1.2 mg/kg/day (max 100 mg). Adults typically start at 40 mg daily, titrated to 80 mg. Capsules should be swallowed whole. Full therapeutic response may take several weeks.Side Effects & Warnings
Common: nausea, decreased appetite, insomnia, and dry mouth. Serious: liver-injury risk, suicidal ideation in youth, and elevated heart rate or blood pressure. Contraindicated with MAOIs or narrow-angle glaucoma.Patient Considerations
Blood-pressure and liver-function monitoring recommended. Take consistently at the same time daily. Do not open capsules.Ready for next steps?
Frequently asked questions
How long does Strattera take to work?
Some improvement appears in 2 weeks, but full effect may take 4–8 weeks.
Can Strattera be taken with coffee?
Moderate caffeine is acceptable, but excess may increase jitteriness.
Is Strattera addictive?
No, it has no stimulant or dependency potential.
Government / NIH sources
Top Products
Meet our doctors
Licensed clinicians with evidence‑based prescribing. Learn about training, interests, and availability.